હોમ › ફેફસાનું કેન્સર › વોશિંગ્ટન › Seattle
Seattle, WA માં ફેફસાનું કેન્સર ક્લિનિકલ ટ્રાયલ્સ
Seattle (લગભગ 30 માઇલની અંદર) ની સાઇટ્સ પર ફેફસાનું કેન્સર માટે 33 અભ્યાસો ભાગીદારો શોધી રહ્યા છે. કોઈ અભ્યાસ ખોલો અને જુઓ કે કોઈ જોડાઈ શકે છે અને અભ્યાસ ટીમ સાથે સંપર્ક કેવી રીતે કરવો.
અધિકૃત અભ્યાસ ટેક્સ્ટ (અંગ્રેજી)
અહીં અભ્યાસ માટે ભરતી કરી રહ્યા છો? આ પેજની ટોચ પર તેને ફીચર કરો — 30 દિવસ માટે $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ભરતી ચાલુ છેફેઝ 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- અને 1 વધુ
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ભરતી ચાલુ છેફેઝ 3
- Swedish Medical Center-First Hill, Seattle
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ભરતી ચાલુ છેફેઝ 3
- Swedish Medical Center-First Hill, Seattle
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
ભરતી ચાલુ છેફેઝ 3
- University of Washington - Fred Hutchinson Cancer Center, Seattle
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
ભરતી ચાલુ છેફેઝ 1/2
- Swedish Medical Center, Seattle
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
ભરતી ચાલુ છેફેઝ 2/3
- Fred Hutchinson Cancer Center, Seattle
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Research Site, Seattle
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
ભરતી ચાલુ છેસ્વસ્થ સ્વેચ્છાએ ભાગ લેનારા સ્વાગત છે
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
ભરતી ચાલુ છેફેઝ 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- Swedish Medical Center, Seattle
- VA Puget Sound Health Care System, Seattle
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
ભરતી ચાલુ છેફેઝ 1/2
- Avenzo Therapeutics Recruiting Site, Seattle
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 3
- Virginia Mason Medical Center, Seattle
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
ભરતી ચાલુ છે
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
ભરતી ચાલુ છેફેઝ 1
- Xencor Investigative Site, Seattle
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
ભરતી ચાલુ છેફેઝ 1/2
- Fred Hutch Cancer Center, Seattle
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
ભરતી ચાલુ છેફેઝ 1/2
- Fred Hutchinson Cancer Research Center, Seattle
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Seattle Cancer Care Alliance, Seattle
SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer
ભરતી ચાલુ છેફેઝ 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
ભરતી ચાલુ છેફેઝ 1/2
- Fred Hutchinson Cancer Center, Seattle
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-First Hill, Seattle
- FHCC at Northwest Hospital, Seattle
- અને 1 વધુ
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ભરતી ચાલુ છેફેઝ 1/2
- Virginia Mason Medical Center, Seattle
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ભરતી ચાલુ છેફેઝ 2
- Swedish Medical Center-First Hill, Seattle
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ભરતી ચાલુ છેફેઝ 1/2
- Virginia Mason Medical Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ભરતી ચાલુ છેફેઝ 1
- Fred Hutchinson Cancer Center, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ભરતી ચાલુ છેઅવલોકનકારી અભ્યાસ
- Massive Bio SYNERGY-AI site, Seattle
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
ભરતી ચાલુ છેફેઝ 1/2
- Fred Hutch Cancer Center, Seattle
અન્ય શહેરોમાં ફેફસાનું કેન્સર ટ્રાયલ્સ
- Houston, TX78 અભ્યાસો
- Boston, MA62 અભ્યાસો
- New York City, NY60 અભ્યાસો
- Los Angeles, CA45 અભ્યાસો
- Arlington, VA41 અભ્યાસો
- Washington, DC41 અભ્યાસો
- Chicago, IL41 અભ્યાસો
- Nashville, TN40 અભ્યાસો
- Baltimore, MD40 અભ્યાસો
- St. Louis, MO39 અભ્યાસો
- Columbus, OH37 અભ્યાસો
- Philadelphia, PA36 અભ્યાસો
Seattle માં અન્ય અભ્યાસો
- નોન-સ્મોલ સેલ લંગ કેન્સર53 અભ્યાસો
- કેન્સર (બધા પ્રકાર)49 અભ્યાસો
- પ્રોસ્ટેટ કેન્સર42 અભ્યાસો
- એક્યુટ માયલોઇડ લ્યુકેમિયા40 અભ્યાસો
- સ્તન કેન્સર39 અભ્યાસો
- મેટાસ્ટેટિક કેન્સર39 અભ્યાસો
- કોલોરેક્ટલ કેન્સર34 અભ્યાસો
- ઓવેરિયન કેન્સર30 અભ્યાસો
- મલ્ટિપલ માયલોમા22 અભ્યાસો
- માયેલોડિસ્પ્લાસ્ટિક સિન્ડ્રોમ્સ21 અભ્યાસો
- એક્યુટ લિમ્ફોબ્લાસ્ટિક લ્યુકેમિયા21 અભ્યાસો
- મૂત્રાશયનો કેન્સર21 અભ્યાસો
ClinicalTrials.gov પરથી, તારીખ 5 ઑક્ટો, 2026 ના ડેટા સાથે. દરેક અભ્યાસની પોતાની પાત્રતા શરતો હોય છે; અભ્યાસ ટીમ નક્કી કરે છે કે કોઈ જોડાઈ શકે છે કે નહીં.